This document contains performance data and financial metrics for an algorithm company over several quarters and years. It also includes stock price projections and purchase recommendations based on the company's indication price compared to its current stock price. The analysis assigns the company a normal investment rating and recommends gradually purchasing its stock over the next 3 months if the price drops to certain levels below the indication price.

1. Performance Analysis of Algorithm (consolidated) 019170 Date
Period 3 months 100-m won
2017.12 2018.12 2019.12 Average 2019.06 2019.09 2019.12 2020.03 2020.06 2020.09
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 1,850 1,874 1,897 1,874 465 480 484 491 500 509 480
O-profit 90 69 20 60 11 41 -48 21 35 58 6
N-income 21 20 18 20 25 9 -25 17 1 0 7
O-rate 4.9 3.7 1.1 3.2 2.4 8.5 -9.9 4.3 7.0 11.4 1.3
N-rate 1.1 1.1 0.9 1.1 5.4 1.9 -5.2 3.5 0.3 0.0 1.4
ROE 1.0 0.9 0.9 0.9 4.6 3.1 1.0 3.0 2.4 2.4 2.9
Debt-ratio 81.6 82.0 81.5 81.7 82.4 80.9 81.5 84.7 85.5 86.3 82.4
Quick-ratio 123.2 125.1 126.8 125.0 125.9 128.2 126.8 128.2 129.7 131.5 127.3
reserve-ratio 745.7 744.2 742.0 744.0 756.5 759.4 742.0 748.2 745.6 742.9 751.5
EPS 38 36 33 36 45 16 -45 31 3 0 12
BPS 3,898 3,836 3,800 3,845 3,929 3,909 3,800 3,829 3,797 3,765 3,867
Dividends 0 0 0 0
2020-06-09
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ -61 %
High mid ~ -66 %
Mid ~ -71 %
Low mid ~ -76 %
Low price ~ -81 %
Indication price Range Current stock price Company score
9,152 W 9,152 W 7,789 W
7,789 W 7,789 W 6,425 W Evaluation
10,515 W 10,515 W~ 9,152 W
27,200 W
40.06,425 W 6,425 W 5,062 W
High price
Normal
5,062 W 5,062 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 79 44 3,119 1,465
5,062원
6,425원
7,789원
9,152원
10,515원
High price 27,200원
-81%
-76%
-71%
-66%
-61%
-90%
-80%
-70%
-60%
-50%
-40%
-30%
-20%
-10%
0.%
0W
5,000W
10,000W
15,000W
20,000W
25,000W
30,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
shinpoong pharm
Gap
shinpoong pharm

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 019170 Date
Period
Gap
(Indication /
stock)
Color
2020-06-09
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
27,200 W High price 57.4 Normal 2,000,000 W
Suggested Purchase
Amount 652,139 W
Number of stocks
purchased 24
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 10,515 W 10,515 W~ ~ 9,152 W -61 % 400,032 W 38
High mid 9,152 W 9,152 W ~ 7,789 W -66 % 432,717 W 47
Mid 7,789 W 7,789 W ~ 6,425 W -71 % 465,401 W 60
Low mid 6,425 W 6,425 W ~ 5,062 W -76 % 498,086 W 78
low price 5,062 W 5,062 W ~ 0 W -81 % 530,771 W 105
Stock price rise
probability score
A Sector 49.5 43.0 52.2 46.8 48.2 50.0
57.4B Sector 47.9 44.2 27.1 46.8 17.9 30.0
Total average
2020.01.10 2020.02.11 2020.03.10 2020.04.07 2020.05.11 2020.06.08
48.7 43.6 39.6 22.9 33.1 40.0
31 % 17 %
2020.02.11 2020.03.10 2020.04.07 2020.05.11 2020.06.08
Total of
increase rate
Total score
A Sector -15 % 18 % -11 % 3 % 4 %
-9 % 44.7B Sector -8 % -63 % 42 % -161 % 40 %
Total average -12 % -10 % -73 %
49
43
52
47 48 5048
44
27
47
18
30
49
44
40
23
33
40
0
10
20
30
40
50
60
2020.01.10 2020.02.11 2020.03.10 2020.04.07 2020.05.11 2020.06.08
Stock price rise probability score
A sector
B sector
Total average
-15%
18%
-11%
3% 4%
-8%
-63%
42%
-161%
40%
-12% -10%
-73%
31%
17%
-200%
-150%
-100%
-50%
0%
50%
100%
2020.02.11 2020.03.10 2020.04.07 2020.05.11 2020.06.08
Increase rate of stock price rise
A sector
B sector
Total average
shinpoong pharm

3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting is o
The Algorithm
accuracy or com
change over tim
results of the d
Consulting bec
②
information pr
investment dec
up
③
do anything th
transaction.
④
The Algorithm
information pr
⑤
analysis report